ClinicalTrialsFinder

Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Clinical Trials in Barcelona

1 recruitingBarcelona, Spain

Showing 1–1 of 1 trials

Recruiting
Phase 2

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Metastatic Non-small Cell Lung Cancer (NSCLC)Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb160 enrolled71 locationsNCT07680764